Endpoint Eclinical India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 01-07-2024
- Paid Up Capital ₹ 0.10 M
as on 01-07-2024
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 17.50%
(FY 2022)
- Profit 8.62%
(FY 2022)
- Ebitda 45.07%
(FY 2022)
- Net Worth 48.88%
(FY 2022)
- Total Assets 31.09%
(FY 2022)
About Endpoint Eclinical India
The Corporate was formerly known as Endpoint Clinical India Private Limited. The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohit Agarwal, Sandeep Thalla, and David Cooper serve as directors at the Company.
- CIN/LLPIN
U72900TG2017FTC121138
- Company No.
121138
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
12 Dec 2017
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Endpoint Eclinical India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Thalla  | Director | 25-Aug-2020 | Current |
| Mohit Agarwal | Director | 27-Dec-2019 | Current |
David Cooper  | Director | 30-Jun-2023 | Current |
Financial Performance and Corporate Structure Insights of Endpoint Eclinical India.
Endpoint Eclinical India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.5% increase. The company also saw a slight improvement in profitability, with a 8.62% increase in profit. The company's net worth Soared by an impressive increase of 48.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Endpoint Eclinical India?
In 2021, Endpoint Eclinical India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Endpoint Eclinical India?
Endpoint Eclinical India has a workforce of 172 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Endpoint Eclinical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Endpoint Eclinical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
